Organization Overview
Alternative names
azacitidine (vidaza) (2 trials)
bone marrow derived mesenchymal stem cells (1 trial)
cyclophosphamide (cytoxan) (1 trial)
cytarabine (cytosar-u) (1 trial)
docetaxel (taxotere) (1 trial)
durvalumab (imfinzi) (1 trial)
emicizumab (Hemlibra) (1 trial)
Acne Vulgaris (Phase 4)
Adenocarcinoma (Phase 2)
Aggression (Phase 2)
Anemia, Iron-Deficiency (Phase 3)
Cardiovascular Diseases (Phase 3)
Dermatitis (Phase 2)
Dermatitis, Atopic (Phase 2)
Diabetes Mellitus (Phase 4)
Diabetes Mellitus, Type 2 (Phase 4)
Diabetic Foot (Phase 3)
Dyslipidemias (Phase 3)
Edema (Phase 4)
Hemophilia A (Phase 2)
Hypoglycemia (Phase 4)
Inflammation (Phase 3)
Ischemia (Phase 3)
Leukemia (Phase 2)
Leukemia, Myeloid (Phase 2)
Leukemia, Myeloid, Acute (Phase 2)
Leukemia, Myeloid, Chronic-Phase (Phase 2)
Lymphoma (Phase 2)
Lymphoma, B-Cell (Phase 2)
Lymphoma, Non-Hodgkin (Phase 2)
Lymphoma, T-Cell (Phase 2)
Macular Edema (Phase 4)
Metabolic Syndrome (Phase 3)
Multiple Myeloma (Phase 2)
Myelodysplastic Syndromes (Phase 2)
Neoplasms, Plasma Cell (Phase 2)
Neurodermatitis (Phase 2)
Pancreatic Neoplasms (Phase 2)
Preleukemia (Phase 2)
Sarcoma (Phase 4)
Sepsis (Phase 2)
Stomach Neoplasms (Phase 2)
Syndrome (Phase 3)
Thrombosis (Phase 3)
Venous Thrombosis (Phase 3)